Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone marrow transplantation: current status.

R Dinsmore, R J O'Reilly

    Pathobiology Annual
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Bone marrow transplantation (BMT) has improved survival rates for fatal diseases, driven by better patient selection. Overcoming current challenges will expand BMT applications to more blood and genetic conditions.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Artificial Antigen Presenting Cells: An Off the Shelf Approach for Generation of Desirable T-Cell Populations for Broad Application of Adoptive Immunotherapy.

    Advancements in genetic engineering·2018
    Same author

    Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis.

    Bone marrow transplantation·2017
    Same author

    Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8<sup>+</sup> T cells for adoptive immunotherapy of cancer and infections.

    Clinical and experimental immunology·2016
    Same author

    Virus-specific T-cell banks for 'off the shelf' adoptive therapy of refractory infections.

    Bone marrow transplantation·2016
    Same author

    Late effects in patients with Fanconi anemia following allogeneic hematopoietic stem cell transplantation from alternative donors.

    Bone marrow transplantation·2016
    Same author

    T-cell depleted allogeneic hematopoietic cell transplants as a platform for adoptive therapy with leukemia selective or virus-specific T-cells.

    Bone marrow transplantation·2015
    Same journal

    Biology of cardiac overload.

    Pathobiology annual·1982
    Same journal

    Parathyroid hormone: chemistry and structure-activity relations.

    Pathobiology annual·1981
    Same journal

    Tamm-Horsfall uromucoprotein and the pathogenesis of casts, reflux nephropathy, and nephritides.

    Pathobiology annual·1981
    See all related articles

    Area of Science:

    • Hematology
    • Oncology
    • Immunology

    Background:

    • Bone marrow transplantation (BMT) has seen significant advancements over the last decade.
    • Improved outcomes have led to increased long-term survival for patients with previously fatal conditions.

    Purpose of the Study:

    • To review the progress and current challenges in bone marrow transplantation.
    • To identify key areas for future research to expand BMT applicability.

    Main Methods:

    • Review of outcomes data from the past decade.
    • Analysis of patient selection criteria contributing to improved results.
    • Identification of limitations and challenges in current BMT practices.

    Main Results:

    Related Experiment Videos

  • Dramatic improvement in BMT outcomes with increased long-term survivors.
  • Advances attributed to better patient selection, particularly in aplastic anemia and early-stage leukemia.
  • Persistent challenges limit the broader success and application of BMT.

    • Conclusions:

    • BMT offers a potential cure for various hematologic and genetic diseases.
    • Addressing current challenges is crucial for extending BMT to a wider range of conditions.
    • Future research should focus on overcoming these limitations to broaden BMT's therapeutic reach.